Simultaneous multivessel percutaneous coronary intervention and transfemoral transcatheter aortic valve implantation with ACURATE neo
Coronary artery disease (CAD), due to common risk factors, often accompanies aortic stenosis (AS) [1]. CAD occurs in 50–75% of patients undergoing transcatheter aortic valve implantation (TAVI) [1]. However, there are no data on the necessity and the extent of revascularization in CAD patients refer...
Guardado en:
Autores principales: | Michał Hawranek, Kamil Bujak, Jan Rychter, Mariusz Gąsior, Michal Zembala |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c230c4190564bfb9ee140c1da263299 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Shockwave and Non-transfemoral Transcatheter Aortic Valve Replacement
por: Eden C Payabyab, et al.
Publicado: (2021) -
Female gender and the clinical and periprocedural profile and clinical outcomes of transcatheter aortic valve implantation: experiences of a tertiary Polish centre
por: Krzysztof Wilczek, et al.
Publicado: (2020) -
Comparison of the results of transcatheter aortic valve implantation in patients with bicuspid and tricuspid aortic valve
por: Piotr Chodór, et al.
Publicado: (2021) -
Transcatheter Balloon-Expandable Valve-in-Valve to Treat Severe Paravalvular Leak Secondary to ACURATE-neo Self-expanding Prosthesis–Annulus Mismatch
por: William Peverill, MBBS, FRCPA, et al.
Publicado: (2021) -
Identifying Patients without a Survival Benefit following Transfemoral and Transapical Transcatheter Aortic Valve Replacement
por: Daniela Geisler, et al.
Publicado: (2021)